Discover
TELO
Telomir Pharmaceuticals, Inc.
1.23
2 x 0.82
2 x 1.47
bid
ask
+
0.11
9.82%
2 @ 04:00 AM
1.14 -0.09 (7.32%)
| Ytd | -7.52% | |
| 1y | -12.14% |
1.13
day range
1.30
0.89
52 week range
2.09
| Open | 1.15 | Prev Close | 1.12 | Low | 1.13 | High | 1.30 | Mkt Cap | 84.59M |
| Vol | 482.02K | Avg Vol | 78.94K | EPS | -1.11 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.25 | Short Ratio | 5.77 | Inst. Own | 6.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 1.16 | 200-d Avg | 1.27 | 1yr Est | 12.15 |
TELO News
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-mark
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares moved upwards by 30.0% to $2.08 during Thursday&#
benzinga.com
Maxim Group Initiates Coverage On Telomir Pharmaceuticals with Buy Rating, Announces Price Target of
Maxim Group analyst Jason McCarthy initiates coverage on Telomir Pharmaceuticals (NASDAQ:TELO) wi
globenewswire.com
Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal
MIAMI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), a clinical-s
benzinga.com
Telomir Announces New Research Findings From Ohio State University College Of Veterinary Medicine Sh
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a clinical-stage biotechnology company developing small
globenewswire.com
Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activit
MIAMI, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a clinical-st